Company: IMNN
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001641172-25-009572
Chunk: 0

Company: Imunon, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
IMUNON, INC.

CONDENSED CONSOLIDATED

BALANCE SHEETS

    March 31, 2025  
    December 31, 2024 

    (Unaudited)  

    ASSETS 

    Current assets: 

    Cash and cash equivalents 
    $2,871,756  
    $5,872,767 
  
    Advances and deposits on clinical programs and other current assets 
     2,220,200  
     2,136,192 
  
    Total current assets 
     5,091,956  
     8,008,959 

    Property and equipment (at cost, less accumulated depreciation and amortization) 
     734,243  
     541,272 

    Other assets: 

    Operating lease right-of-use assets, net 
     985,887  
     1,117,133 
  
    Deposits and other assets 
     50,000  
     50,000 
  
    Total other assets 
     1,035,887  
     1,167,133 

    Total assets 
    $6,862,086  
    $9,717,364 

See accompanying notes to the unaudited condensed
consolidated financial statements.

1

IMUNON, INC.

CONDENSED CONSOLIDATED

BALANCE SHEETS

(Continued)

    March 31, 2025  
    December 31, 2024 

    (Unaudited)  

    LIABILITIES AND STOCKHOLDERS’ EQUITY 

    Current liabilities: 

    Accounts payable – trade 
    $1,858,602  
    $1,300,026 
  
    Other accrued liabilities 
     3,543,407  
     3,033,747 
  
    Operating lease liability - current portion 
     394,878  
     452,358 
  
    Total current liabilities 
     5,796,887  
     4,786,131 

    Operating lease liability - non-current portion 
     613,171  
     686,935 
  
    Total liabilities 
     6,410,058  
     5,473,066 

    Commitments and contingencies 
     -  
     – 

    Stockholders’ equity: